News FocusTHOMAS MONATH PROFILE

Riding the Biodefense Wave

+ See all authors and affiliations

Science  15 Aug 2003:
Vol. 301, Issue 5635, pp. 912-913
DOI: 10.1126/science.301.5635.912

You are currently viewing the summary.

View Full Text

Summary

CAMBRIDGE, MASSACHUSETTS-- An infectious disease researcher-turned-entrepreneur has used strong scientific credentials, an aversion to risk, a stroke of luck, and enviable connections to turn a company on the verge of collapse into a profitable producer of biodefense vaccines.